Dosage of iBCG and trend of frequency of iBCG-ReA between 1997-2007 and 2007-2017.

Table 2: Dosage of iBCG and trend of frequency of iBCG-ReA between 1997-2007 and 2007-2017.

1997-2007 (187 cases)

2007-2017 (368 cases)

iBCG dose(Immunobladder ^®)

80 mg/dose in 143/187 cases;

40 mg/dose in 44/187 cases;

80 mg/dose in 3 developed cases

40 mg/dose in 1 developed case

80 mg/dose in 102/368 cases;

40 mg/dose in 266/368 cases;

80 mg/dose in 2 developed cases;

40 mg/dose in 5 developed cases

Frequency

4/187 cases (2.1%)

7/368 (1.9%)

ReA: Reactive Arthritis; "developed case" means case developed ReA.